Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?

scientific article published on 24 February 2017

Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/ACSCHEMNEURO.7B00034
P698PubMed publication ID28233992

P50authorHarry W M SteinbuschQ55178235
P2093author name stringPatricia Muñoz
Juan Segura-Aguilar
Andrea Herrera
P433issue4
P921main subjectParkinson's diseaseQ11085
dopamineQ170304
P304page(s)702-711
P577publication date2017-02-24
P1433published inACS Chemical NeuroscienceQ2819059
P1476titleAre Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
P478volume8

Reverse relations

cites work (P2860)
Q54966634Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease.
Q61814946Are Proteinopathy and Oxidative Stress Two Sides of the Same Coin?
Q55430577Can we conclude a potential therapeutic action for Parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?
Q54940982Casein kinase 1α: biological mechanisms and theranostic potential.
Q55048859Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.
Q64097613Chinese Herbal Complex 'Bu Shen Jie Du Fang' (BSJDF) Modulated Autophagy in an MPP-Induced Cell Model of Parkinson's Disease
Q91121458Chromaffin Cells of the Adrenal Medulla: Physiology, Pharmacology, and Disease
Q89303128Comment on: "Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease"
Q38704492DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers.
Q60949804Dopamine Autoxidation Is Controlled by Acidic pH
Q39294770Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky
Q58697824Natural Molecules From Chinese Herbs Protecting Against Parkinson's Disease via Anti-oxidative Stress
Q48291354Neurotoxins as Preclinical Models for Parkinson's Disease
Q57808800Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic
Q89475540On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo
Q41043688On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
Q99631264Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease
Q64075638Plant Extracts and Phytochemicals Targeting -Synuclein Aggregation in Parkinson's Disease Models
Q52723440Reciprocal Interactions of Mitochondria and the Neuroimmunoendocrine System in Neurodegenerative Disorders: An Important Role for Melatonin Regulation.
Q90043966Selective vulnerability in α-synucleinopathies
Q46132067Updates on immunity and inflammation in Parkinson disease pathology